801 related articles for article (PubMed ID: 19758184)
1. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
[TBL] [Abstract][Full Text] [Related]
2. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
3. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
Yang Y; Santamaria P
J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
[No Abstract] [Full Text] [Related]
4. Development of insulitis and diabetes in B cell-deficient NOD mice.
Yang M; Charlton B; Gautam AM
J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
[TBL] [Abstract][Full Text] [Related]
5. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
6. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse.
Dahlén E; Dawe K; Ohlsson L; Hedlund G
J Immunol; 1998 Apr; 160(7):3585-93. PubMed ID: 9531322
[TBL] [Abstract][Full Text] [Related]
8. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice.
Serreze DV; Fleming SA; Chapman HD; Richard SD; Leiter EH; Tisch RM
J Immunol; 1998 Oct; 161(8):3912-8. PubMed ID: 9780157
[TBL] [Abstract][Full Text] [Related]
9. T cells to a dominant epitope of GAD65 express a public CDR3 motif.
Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E
Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112
[TBL] [Abstract][Full Text] [Related]
10. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.
Silveira PA; Grey ST
Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840
[TBL] [Abstract][Full Text] [Related]
11. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.
Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV
Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557
[TBL] [Abstract][Full Text] [Related]
12. Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice.
Brauner H; Elemans M; Lemos S; Broberger C; Holmberg D; Flodström-Tullberg M; Kärre K; Höglund P
J Immunol; 2010 Mar; 184(5):2272-80. PubMed ID: 20130214
[TBL] [Abstract][Full Text] [Related]
13. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
[No Abstract] [Full Text] [Related]
14. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.
Mizuno M; Masumura M; Tomi C; Chiba A; Oki S; Yamamura T; Miyake S
J Autoimmun; 2004 Dec; 23(4):293-300. PubMed ID: 15571923
[TBL] [Abstract][Full Text] [Related]
15. Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes.
Funda DP; Kaas A; Tlaskalová-Hogenová H; Buschard K
Diabetes Metab Res Rev; 2008; 24(1):59-63. PubMed ID: 17607660
[TBL] [Abstract][Full Text] [Related]
16. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells.
Mariño E; Batten M; Groom J; Walters S; Liuwantara D; Mackay F; Grey ST
Diabetes; 2008 Feb; 57(2):395-404. PubMed ID: 18025414
[TBL] [Abstract][Full Text] [Related]
17. Diabetes results from a late change in the autoimmune response of NOD mice.
Gazda LS; Charlton B; Lafferty KJ
J Autoimmun; 1997 Jun; 10(3):261-70. PubMed ID: 9218753
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms mediating anti-CD3 antibody efficacy: insights from a mathematical model of type 1 diabetes.
Young DL; Ramanujan S; Kreuwel HT; Whiting CC; Gadkar KG; Shoda LK
Ann N Y Acad Sci; 2006 Oct; 1079():369-73. PubMed ID: 17130581
[TBL] [Abstract][Full Text] [Related]
19. Endogenous ecotropic murine leukemia viral (MuLV) envelope protein as a new autoantigen reactive with non-obese diabetic mice sera.
Choi SE; Kim KS; Kim KH; Choi UY; Kim HM; Yoon JW; Kang Y
J Autoimmun; 2000 Nov; 15(3):347-57. PubMed ID: 11040075
[TBL] [Abstract][Full Text] [Related]
20. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice.
Greeley SA; Katsumata M; Yu L; Eisenbarth GS; Moore DJ; Goodarzi H; Barker CF; Naji A; Noorchashm H
Nat Med; 2002 Apr; 8(4):399-402. PubMed ID: 11927947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
